These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia. Schepisi C; Cianci S; Bedse G; Fu J; Gaetani S; Nencini P Psychopharmacology (Berl); 2014 Oct; 231(19):3889-97. PubMed ID: 24647922 [TBL] [Abstract][Full Text] [Related]
64. Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment. Vieweg WV; Leadbetter RA CNS Drugs; 1997 Feb; 7(2):121-38. PubMed ID: 23338131 [TBL] [Abstract][Full Text] [Related]
65. Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia. Goldman MB; Gomes AM; Carter CS; Lee R Psychopharmacology (Berl); 2011 Jul; 216(1):101-10. PubMed ID: 21301811 [TBL] [Abstract][Full Text] [Related]
66. Structural pathology underlying neuroendocrine dysfunction in schizophrenia. Goldman MB; Wang L; Wachi C; Daudi S; Csernansky J; Marlow-O'Connor M; Keedy S; Torres I Behav Brain Res; 2011 Mar; 218(1):106-13. PubMed ID: 21093493 [TBL] [Abstract][Full Text] [Related]
67. Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli. Taylor SB; Taylor AR; Markham JA; Geurts AM; Kanaskie BZ; Koenig JI Physiol Behav; 2011 Aug; 104(2):205-14. PubMed ID: 21092742 [TBL] [Abstract][Full Text] [Related]
68. The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness. Goldman MB Brain Res Rev; 2009 Oct; 61(2):210-20. PubMed ID: 19595703 [TBL] [Abstract][Full Text] [Related]
69. A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism. Chan HY; Chang CJ; Chiang SC; Chen JJ; Chen CH; Sun HJ; Hwu HG; Lai MS J Psychopharmacol; 2010 Jan; 24(1):91-8. PubMed ID: 18801830 [TBL] [Abstract][Full Text] [Related]
70. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Goldman M; Marlow-O'Connor M; Torres I; Carter CS Schizophr Res; 2008 Jan; 98(1-3):247-55. PubMed ID: 17961988 [TBL] [Abstract][Full Text] [Related]
71. Brain circuit dysfunction in a distinct subset of chronic psychotic patients. Goldman MB Schizophr Res; 2014 Aug; 157(1-3):204-13. PubMed ID: 24994556 [TBL] [Abstract][Full Text] [Related]
72. Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia. Goldman MB; Blake L; Marks RC; Hedeker D; Luchins DJ Am J Psychiatry; 1993 Apr; 150(4):653-5. PubMed ID: 8465887 [TBL] [Abstract][Full Text] [Related]
74. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia. Jakovljević M; Mück-Seler D; Pivac N; Crncević Z Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670 [TBL] [Abstract][Full Text] [Related]
75. Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis. Kaneko M; Murata S; Hoshino Y; Takahagi K; Yokoyama F; Watanabe M; Kumashiro H Neuropsychobiology; 1990-1991; 24(1):12-6. PubMed ID: 2132636 [TBL] [Abstract][Full Text] [Related]